JPRN-UMIN000005012已完成未知
Evaulation of the clinical efficacy and safety of the combined administration of Imidafenacin and Tamsulosin in BPH patients (in which OAB symptoms remain) who did not respond to alpha-1 blocker monotherapy. - Addition Study
Department of Urology, University of Yamanashi, School of Medicine0 个研究点目标入组 300 人开始时间: 2011年2月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •(1)Patients who have administered prohibited substances or who have administered prohibited therapy in the 8 weeks prior to the 1st period (2)Patients who changed the dosage or usage of a restricted medicine in the specified period before the 1st period (3)Patients with anuresis (4)Patients with prostate cancer, neurogenic bladder, urethra stricture, chronic prostatitis, symptomatic urinary tract infection, urinary tract stones and interstitial cystitis (5)Patients with serious cardiac disorder, serious liver dysfunction and serious kidney dysfunction (6)Patients with orthostatic hypotension (7)Patients with pyloristenosis,constriction of dodecadactylon, construction of enteron and adynamic ileus (8)Patients with deterioration of enterokinesis (9)Patients with angle-closure glaucoma (10) Patients with myasthenia gravis. (11) Patients in which it has been confirmed that Qmax is less than 5mL/s. (12)Patients with Polyuria. (13)Any other patients who are regarded as unsuitable for this study by the investigator
研究者
相似试验
进行中（未招募）
1 期
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.MedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004891-16-LVInstitut de Recherches Internationales Servier968
招募中
不适用
Evaluation of the clinical efficacy and safety of fluticasone propionate/ formoterol fumarate combination (FFC) for the treatment of bronchial asthma-with and without use of an inhalation deviceBronchial AsthmaJPRN-UMIN000015602Kinki university Department of respiratory medicine and allergology50
进行中（未招募）
1 期
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.MedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004891-16-CZInstitut de Recherches Internationales Servier968
进行中（未招募）
1 期
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.MedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004891-16-PLInstitut de Recherches Internationales Servier968
进行中（未招募）
1 期
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.MedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersHypertensionEUCTR2020-004891-16-HUInstitut de Recherches Internationales Servier968